Marinomed Biotech AG reports best first quarter in company history
Marinomed Biotech AG with Carragelose record sales in 2022 and positive outlook for 2023
Marinomed Biotech AG publishes clinical data on the effectiveness of its Carragelose nasal spray in the treatment of hay fever
Marinomed Biotech AG reports positive clinical data for the Carragelose decongestant nasal spray
Lucia Ziegler, MSc
IR & PR Manager